In a later study, these authors reported prevalence rates for this mutation of 3.2, 1.6, and 4.9% among Iranian T2DM patients, T2DM patients with microalbuminuria, and normoalbuminuric T2DM patients, respectively, suggesting that the FVL G1691A mutation is not associated with microalbuminuria in this population (14). Here, F5 is linked to type 2 diabetes mellitus.